FINWIRES · TerminalLIVE
FINWIRES

$SCTX

3 stories mentioning SCTXUpdated just now

Every FINWIRES story that references SCTX, newest first.

Wire

Top Midday Gainers

Scribe Therapeutics (SCTX) has priced an upsized initial public offering of 8.6 million shares at $15 apiece, it said late Thursday.Additionally, Scribe Therapeutics agreed to sell 500,000 of its shares at $15 apiece to Sanofi (SNY) in a concurrent private placement, which is expected to close on Monday.Shares of Scribe Therapeutics surged 47%. Intraday trading volume stood at over 544,000.Safety Insurance (SAFT) stock soared 41% amid heavy trading after the company agreed to be acquired by an affiliate of Mapfre in a $1.54 billion all-cash deal, it said late Thursday.More than 691,000 shares of Safety Insurance traded intraday compared with a daily average of about 113,000.NIP (NIPG) has regained compliance with Nasdaq's minimum bid price requirement after receiving confirmation from the exchange on July 21, the company said Friday.Shares jumped 35%, with intraday trading volume rising to more than 56,000 versus the stock's daily average of about 11,000.Price: $22.56, Change: $+7.56, Percent Change: +50.37%

$NIPG$SAFT$SCTX$SNY
Sectors

Sector Update: Healthcare Stocks Rise in Afternoon Trading

Healthcare stocks rose Friday afternoon, with the NYSE Healthcare Index and the State Street Health Care Select Sector SPDR ETF (XLV) each adding about 0.8%.The iShares Biotechnology ETF (IBB) increased 0.2%.In corporate news, Novo Nordisk (NVO) is seeking a preliminary US court injunction to immediately block advertising by Eli Lilly (LLY) for its obesity and diabetes drugs, escalating the companies' legal dispute over weight-loss drug marketing, Reuters reported Friday. Novo shares rose 1.7%, and Lilly was up 1.3%.Tenet Healthcare (THC) shares jumped past 17% after it posted higher Q2 adjusted earnings and revenue, and raised its 2026 guidance.Scribe Therapeutics (SCTX) shares surged 50% in their Friday debut on Nasdaq after the company priced its IPO of 8.58 million shares at $15 per share.

$LLY$NVO$SCTX$THC
Wire

Scribe Therapeutics Shares Rise in Nasdaq Debut

Scribe Therapeutics (SCTX) shares were up sharply in their Friday debut on Nasdaq after the company priced its initial public offering of 8.58 million shares at $15.00 per share.The stock opened at $25 and was up over 50% at around $22.61 after midday.The clinical-stage biotechnology company has upsized its IPO after pricing the shares at the high end of its indicative range.It has granted its underwriters a 30-day option to purchase up to almost 1.3 million additional shares. Leerink Partners, Goldman Sachs, Guggenheim Securities and Wells Fargo Securities are joint book-running managers for the offering.Price: $22.61, Change: $+7.61, Percent Change: +50.75%

$SCTX

Track with the FINWIRES app suite